missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Nimodipine Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Supplier: Merck Emd Millipore PHR12931G
Description
Nimodipine is a well-known calcium antagonist and is a moderate cerebral vasodilator, in addition to being an inhibitor of cerebrovascular reactivity. It is suggested to be cytoprotective by causing a decrease in the influx of calcium into the nerve cells. It is accepted for use in the management of delayed ischaemic dysfunction and is commonlly used in the studies of brain function impairment and dementia in old age.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Specifications
| 66085-59-4 | |
| Neat | |
| MFCD00153848 | |
| Certified Reference Material | |
| 418.44 |
| These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available. | |
| C21H26N2O7 | |
| Nimodipine; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester; Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate | |
| 1 g | |
| Certified Reference Material |